Becton, Dickinson and Company (BDX)
NYSE: BDX · Real-Time Price · USD
175.34
+8.12 (4.86%)
At close: May 12, 2025, 4:00 PM
175.10
-0.24 (-0.14%)
After-hours: May 12, 2025, 7:27 PM EDT
BDX Market Cap
BDX has a market cap or net worth of $50.25 billion as of May 12, 2025. Its market cap has decreased by -25.61% in one year.
Market Cap
50.25B
Enterprise Value
68.63B
1-Year Change
-25.61%
Ranking
Category
Stock Price
$175.34
Market Cap Chart
Since December 1, 1998, BDX's market cap has increased from $10.89B to $50.25B, an increase of 361.34%. That is a compound annual growth rate of 5.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 47.93B | -26.93% |
| Dec 31, 2024 | 65.59B | -7.37% |
| Dec 29, 2023 | 70.81B | -1.74% |
| Dec 30, 2022 | 72.06B | 0.89% |
| Dec 31, 2021 | 71.43B | -1.58% |
| Dec 31, 2020 | 72.57B | -1.34% |
| Dec 31, 2019 | 73.56B | 21.69% |
| Dec 31, 2018 | 60.44B | 23.86% |
| Dec 29, 2017 | 48.80B | 38.84% |
| Dec 30, 2016 | 35.15B | 8.24% |
| Dec 31, 2015 | 32.47B | 21.55% |
| Dec 31, 2014 | 26.72B | 24.57% |
| Dec 31, 2013 | 21.45B | 39.26% |
| Dec 31, 2012 | 15.40B | -4.09% |
| Dec 30, 2011 | 16.06B | -17.39% |
| Dec 31, 2010 | 19.44B | 3.94% |
| Dec 31, 2009 | 18.70B | 12.46% |
| Dec 31, 2008 | 16.63B | -18.44% |
| Dec 31, 2007 | 20.39B | 17.82% |
| Dec 29, 2006 | 17.30B | 14.26% |
| Dec 30, 2005 | 15.14B | 5.26% |
| Dec 31, 2004 | 14.39B | 37.33% |
| Dec 31, 2003 | 10.48B | 32.87% |
| Dec 31, 2002 | 7.88B | -8.07% |
| Dec 31, 2001 | 8.58B | -2.81% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 653.13B |
| Johnson & Johnson | 365.27B |
| UnitedHealth Group | 344.77B |
| AbbVie | 320.43B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 228.56B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |